ArticleJournal of Zhejiang University. Science. B2023

Development and validation of a risk-prediction model for immune-related adverse events in patients with non-small-cell lung cancer receiving PD-1/PD-L1 inhibitors.

Qing Qiu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.